BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220124
DTEND;VALUE=DATE:20220126
DTSTAMP:20260515T235350
CREATED:20211025T110453Z
LAST-MODIFIED:20211217T125420Z
UID:31919-1642982400-1643155199@www.pharmajournalist.com
SUMMARY:SMi’s Transdermal and Microneedle Delivery
DESCRIPTION:SMi’sTransdermal and Microneedle Delivery\n24-25 January 2022\nWorkshop: 26th January 2022\nVirtual Conference: Online Access Only\nwww.transdermal-microneedle-delivery.co.uk/PharmajournalistWL\n#SMiTransdermal \nSponsored by: LTS Lohmann Therapie-Systeme AG and QuadMedicine \nCo-Chaired by: \nSanjiv Sharma\, Senior Lecturer in Medical Engineering\, Swansea University \nTycho Speaker\, Director\, Drug Delivery and Biomaterials\, AbbVie Ltd \nSMi’s inaugural conference: Transdermal and Microneedle delivery will take place on 24th – 25th January 2022 \nSMi is proud to present the Transdermal and Microneedle Drug Delivery Conference\, taking place on the 24th to 25th January 2022\, Virtual Conference: Online Access Only. Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for device design while engaging in the latest innovations in device design and formulation with case studies from thought leaders. \nThe conference will consider key developments in the transdermal drug delivery field\, including the innovations in microneedle technology for a COVID-19 vaccine and opportunities for development in cancer vaccine delivery\, advances in microarray patches\, and microneedle-based diagnostics. Key regulatory updates including guidance on classification of microneedle devices and considerations for ensuring quality will be presented by regulatory experts for a comprehensive outlook of this exciting and ever-growing field\, and the importance of considering human factors in order to enhance the user experience will be presented by industry experts. \nThis two-day agenda offers you peer-to-peer networking with leaders in transdermal and microneedle delivery. We look forward to welcoming you to the conference in January. \nKey Reasons to Attend: \n\nGain insight into developments in microneedles for drug delivery and diagnostics\nHear key regulatory updates from regulatory bodies including FDA and WHO on guidance for regulatory compliance\nExplore new applications of microneedle technology in vaccinations\nDiscover advances in design and application of transdermal patches\nExplore and benchmark against industry developments through case studies and real world examples in device development for microneedles\n\nDownload the brochure at: www.transdermal-microneedle-delivery.co.uk/PharmajournalistWL \nWho Should Attend? \n\nDrug-Delivery  Device Developers\nMicroneedle Device Developers\nTransdermal Delivery  Developers\nMicroarray Patch Developers\nMedical Device Engineers\nPrimary Packaging Material DesignersSecondary Packagers\nSmart Device Developers\nTraining Device Developers\nDevice-Safety Solution Providers\nDrug Developers\nTransdermal Drug Product Developers
URL:https://www.pharmajournalist.com/event/transdermal-and-microneedle-delivery/
LOCATION:Virtual Conference: Online Access Only
ORGANIZER;CN="SMi Group Ltd":MAILTO:RJones@smi-online.co.uk
END:VEVENT
END:VCALENDAR